ITOS
iTeos Therapeutics
ITOS
ITOS
Delisted
ITOS was delisted on the 28th of August, 2025.
145 hedge funds and large institutions have $460M invested in iTeos Therapeutics in 2023 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 56 increasing their positions, 47 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
145
Holders Change
-7
Holders Change %
-4.61%
% of All Funds
2.29%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
18
Increased
56
Reduced
47
Closed
25
Calls
$1.38M
Puts
$1.01M
Net Calls
+$367K
Net Calls Change
+$993K
Top Buyers
| 1 |
1
Millennium Management
New York
|
$10.9M |
| 2 |
2
Bank of Montreal
Toronto,
Ontario, Canada
|
$3.1M |
| 3 |
3
BlackRock
New York
|
$62M |
| 4 |
4
Goldman Sachs
New York
|
$8.52M |
| 5 |
5
Dimensional Fund Advisors
Austin,
Texas
|
$7.66M |
Top Sellers
| 1 |
1
JPMorgan Chase & Co
New York
|
$271K |
| 2 |
2
Morgan Stanley
New York
|
$2.34M |
| 3 |
3
Invesco
Atlanta,
Georgia
|
$2.85M |
| 4 |
4
State Street
Boston,
Massachusetts
|
$20.7M |
| 5 |
5
Citadel Advisors
Miami,
Florida
|
$15.8M |
